title: Cyclooxygenase-2 inhibitors and other NSAIDs in urology: current peril or future promise?
authors.affiliation: Division of Urologic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA. rpruthi@med.unc.edu
authors.forename: Raj S
authors.initials: RS
authors.lastname: Pruthi
authors.forename: Erik
authors.initials: E
authors.lastname: Kouba
authors.forename: Culley C
authors.initials: CC
authors.lastname: Carson
authors.forename: Eric M
authors.initials: EM
authors.lastname: Wallen
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000139:chemically induced; D051546:Cyclooxygenase 2 / Q000502:physiology; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D005544:Forecasting; D006801:Humans; D014570:Urologic Diseases / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D051546:Cyclooxygenase 2